Ken Herrmann, Director at Aktis Oncology, Inc. (AKTS), sold 4,856 shares at $24.56 ($119K) on 2026-07-20, disclosed to the SEC on 2026-07-21.
Open-market sale of $119k AKTS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.56 | 1,350 | $33K | 27.8% |
| 2 | $24.56 | 3,506 | $86K | 72.2% |
| Total | $24.56 avg | 4,856 | $119K | 100% |